Skip to main content
. 2022 Dec 12;46(Suppl 1):s49–s67.2. doi: 10.2337/dc23-S004

Table 4.3.

Assessment of hypoglycemia risk

Factors that increase risk of treatment-associated hypoglycemia
 • Use of insulin or insulin secretagogues (i.e., sulfonylureas, meglitinides)
 • Impaired kidney or hepatic function
 • Longer duration of diabetes
 • Frailty and older age
 • Cognitive impairment
 • Impaired counterregulatory response, hypoglycemia unawareness
 • Physical or intellectual disability that may impair behavioral response to hypoglycemia
 • Alcohol use
 • Polypharmacy (especially ACE inhibitors, angiotensin receptor blockers, nonselective β-blockers)
 • History of severe hypoglycemic event
In addition to individual risk factors, consider use of comprehensive risk prediction models (233).

See references 234238.